Growth Capitalist (https://growthcapitalist.com/author/moriarty/page/179/)
Hemispherx Biopharma, Inc. (HEB) announced that it has secured up to $75,000,000 in an ATM (At the Market) transaction with Maxim Group. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was Ellenoff Grossman & Schole and issuer counsel was Silverman, Sclar, Shin & Byrne. Note that this Placement is a re-issuance of a cancelled Equity Line. via PlacementTracker.
Geron Corporation (GERN) announced that it has raised $90,000,000 in a CMPO/Overnight transaction. The common stock was sold at $4.00 per share, an approximate 8% discount to the market price ($4.33) of GERN at deal announcement. Bank of America Merrill Lynch acted as Sole Book-Runner, Stifel Nicolaus Weisel acted as Lead Manager, and Lazard, Piper Jaffray, and MLV acted as Co-Managers on the transaction. Underwriter counsel was Davis Polk & Wardwell and issuer counsel was Cooley LLP. The transaction is expected to close by 02/04/2014. via PlacementTracker.
Top Image Systems Limited (TISA) announced that it has raised $13,062,500 in a CMPO/Overnight transaction. The common stock was sold at $4.75 per share, an approximate 13% discount to the market price ($5.47) of TISA at deal announcement. Canaccord Genuity Inc. (US) acted as Sole Book-Running Manager with Roth Capital Partners, LLC and Benchmark Company, LLC acted as Co-Managers on the transaction. Underwriter counsel was Choate, Hall & Stewart, LLP and issuer counsel was CBLS Law Offices and Schwell Wimpfheimer & Associates LLP. via PlacementTracker.
MELA Sciences Inc. (MELA) announced that it has raised $12,450,000 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.84 per share, an approximate 12.46% premium to the market price ($0.75) of MELA at deal announcement. A series of 13,297,29 60-Month Warrants with an exercise price of $0.74 per share (0.92382% discount) was issued to the investors in this transaction. Craig-Hallum Capital Group LLC acted as the exclusive agent on the transaction. The investors were Broadfin Capital and Sabby Management. In conjunction with the financing, The Company’s directors have agreed to purchase $150,000 in restricted common stock priced at $0.74 per share.
